Straumann Holding AG (SWX:STMN)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 14.98B +1.1% |
| Revenue (ttm) | 2.64B +2.2% |
| Net Income | 369.18M -6.4% |
| EPS | 2.31 -6.6% |
| Shares Out | 159.45M |
| PE Ratio | 40.67 |
| Forward PE | 26.66 |
| Dividend | 1.00 (1.04%) |
| Ex-Dividend Date | Apr 21, 2026 |
| Volume | 330,246 |
| Open | 95.02 |
| Previous Close | 95.02 |
| Day's Range | 93.94 - 95.56 |
| 52-Week Range | 73.02 - 109.80 |
| Beta | 1.37 |
| Analysts | Buy |
| Price Target | 111.44 (+18.63%) |
| Earnings Date | Aug 19, 2026 |
About Straumann Holding AG
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent toot... [Read more]
Financial Performance
In 2025, Straumann Holding AG's revenue was 2.61 billion, an increase of 4.05% compared to the previous year's 2.50 billion. Earnings were 355.92 million, a decrease of -8.34%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for STMN stock is "Buy." The 12-month stock price target is CHF 111.44, which is an increase of 18.63% from the latest price.
News
Bangkok Hospital launches dental education centre
Bangkok Hospital Dental Center and Switzerland-based Straumann Group have launched Thailand's first Straumann Center of Dental Education (CoDE) as growing use of digital technologies drives demand for...
Straumann Holding AG Earnings Call Transcript: Q2 2026
Strong H1 2026 results featured robust revenue and margin growth, driven by digital adoption, operational excellence, and market share gains across all regions. Upgraded guidance calls for high single-digit organic growth and improved EBIT margin, with continued investment in innovation and digital transformation.
Straumann Holding AG Slides: Q2 2026
Straumann Holding AG has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 19, 2026.
Straumann Holding AG Earnings release: Q2 2026
Straumann Holding AG released its Q2 2026 earnings on August 19, 2026, summarizing the period's financial results.
Straumann posts H1 sales in line with estimates, maintains outlook
Swiss dental implants maker Straumann reported half-year sales broadly in line with market expectations and confirmed its annual guidance on Wednesday.
Straumann CEO Guillaume Daniellot To Step Down; Appoints Christopher Norbye As Successor
(RTTNews) - Straumann Holding AG (SAUHY, STMN.SW), a Swiss-based provider of dental solutions, on Wednesday announced that its Chief Executive Officer Guillaume Daniellot will step down. The company h...
Straumann Shares Climb After Lower-Than-Expected Tariffs Boost Outlook
The dental-implant company's stock was up 9.7% after it raised its profitability outlook for the year, citing lower-than-anticipated tariffs and cost savings.
Straumann Holding AG Earnings Call Transcript: Q1 2026
Q1 2026 saw 7.1% organic revenue growth, led by strong gains in Latin America, EMEA, and North America, with robust innovation and digital adoption driving market share. Margin guidance is reaffirmed despite FX headwinds and China VBP uncertainty, supported by operational efficiencies.
Straumann Holding AG Slides: Q1 2026
Straumann Holding AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Straumann Holding AG Earnings release: Q1 2026
Straumann Holding AG released its Q1 2026 earnings on April 29, 2026, summarizing the period's financial results.
Straumann Holding AG Earnings Call Transcript: Q4 2025
Revenue grew 8.9% organically to CHF 2.6 billion in 2025, with strong EBIT margin and cash flow despite currency and tariff headwinds. Innovation, digitalization, and regional expansion drove growth, while 2026 guidance anticipates high single-digit organic growth and margin improvement.
Straumann Holding AG Earnings release: Q4 2025
Straumann Holding AG released its Q4 2025 earnings on February 18, 2026, summarizing the period's financial results.
Straumann Holding AG Annual report: Q4 2025
Straumann Holding AG has published its Q4 2025 annual report on February 18, 2026.
Straumann Holding AG Slides: Q4 2025
Straumann Holding AG has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 18, 2026.
Straumann Holding AG Transcript: CMD 2025
Aiming for 10% CAGR revenue and 40–50 bps EBIT margin growth (2026–2030), the group leverages innovation, digitalization, and a multi-brand strategy to expand in under-penetrated dental markets. Transformation in ortho and digital, cost efficiencies, and local manufacturing underpin profitability, while FX and regulatory risks are actively managed.
Straumann Holding AG Press release: FY 2025
Straumann Holding AG issued a press release on November 25, 2025, disclosing material business information to investors.
Straumann Holding AG Slides: FY 2025
Straumann Holding AG has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 25, 2025.
Straumann Holding AG Earnings Call Transcript: Q3 2025
Q3 saw 8.3% organic revenue growth, led by EMEA and Latin America, with strong innovation and strategic partnerships in orthodontics and digital. Despite headwinds in China and tariffs, full-year guidance for high single-digit growth and margin improvement is confirmed.
Straumann Holding AG Earnings release: Q3 2025
Straumann Holding AG released its Q3 2025 earnings on October 29, 2025, summarizing the period's financial results.
Straumann Holding AG Slides: Q3 2025
Straumann Holding AG has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on October 29, 2025.
Straumann H1 sales grow on sustained demand
Swiss dental implant maker Straumann on Wednesday reported organic sales growth of 10.2% for the first half of the year, citing sustained demand.